by adminAdrianRamirez | Jan 11, 2017 | HempMeds, Media Coverage, Press Releases
Interview Portrays the Benefits of Cannabis-Related Products to Millions of Chinese Viewers Around the World SAN DIEGO, Jan. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) is pleased to announce that the Company’s CEO was featured in a series...
by adminAdrianRamirez | Jan 10, 2017 | Axim Biotechnologies, Press Releases
NEW YORK, Jan 10, 2017 — AXIM Biotechnologies, Inc. (AXIM Biotech) AXIM, +23.30% a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM Biotech, is meeting with business...
by adminAdrianRamirez | Jan 9, 2017 | Axim Biotechnologies, Press Releases
AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA — (Marketwired) — 01/09/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded...
by adminAdrianRamirez | Jan 6, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, CA — (Marketwired) — 01/06/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest...
by adminAdrianRamirez | Jan 5, 2017 | HempMeds Brasil, Press Releases
Partnership to Provide Expanded Accessibility to RSHO(TM), the First-Ever Product Approved for Import by Brazilian Government SAN DIEGO, CA — (Marketwired) — 01/05/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis...
